SCHEMBL8095741

SCHEMBL8095741

N#Cc1cc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(F)cc2)nc1SCc1ccc2ccccc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 7/20 0.43
TSHR P16473 2/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
HBB P68871 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PTGS2 P35354 3/20 0.41
PTGS1 P23219 2/20 0.41
CA12 O43570 3/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA9 Q16790 3/20 0.40
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8092688 0.91 MAPK13 (0.43) PDE10ATSHRTP53MAPTHPGD
SCHEMBL8519904 0.89 TSHR (0.41) PDE10ATSHRTP53MAPTHPGD
SCHEMBL8094384 0.84 MAPK13 (0.47) LMNAALDH1A1PTGS2PTGS1CA12
SCHEMBL8086490 0.80 ALDH1A1 (0.42) LMNAALDH1A1PTGS2PTGS1CA12
SCHEMBL8519903 0.80 MAPT (0.41) PDE10ATSHRTP53MAPTHPGD
SCHEMBL8095193 0.80 CNR1 (0.46) LMNAALDH1A1PTGS2PTGS1CA12
SCHEMBL8086039 0.80 TSHR (0.50) TSHRMAPTHPGDALOX15SMN1; SMN2
SCHEMBL8104361 0.79 ALDH1A1 (0.46) HPGDLMNAALDH1A1PTGS2PTGS1
SCHEMBL8093245 0.79 ALDH1A1 (0.45) TSHRHPGDLMNAALDH1A1PTGS2
SCHEMBL8095485 0.79 ALDH1A1 (0.44) LMNAALDH1A1PTGS2PTGS1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP disclosed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO disclosed